A Multicenter, Double-Blind, Randomized, Parallel-Group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Subjects With Partial Seizures
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 15 Jun 2012 Additional location (South Korea) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Additional location identified as reported by ClinicalTrials.gov.
- 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History